4//SEC Filing
NovaBay Pharmaceuticals, Inc. 4
Accession 0001437749-16-031871
$NBYCIK 0001389545operating
Filed
May 12, 8:00 PM ET
Accepted
May 13, 5:07 PM ET
Size
5.1 KB
Accession
0001437749-16-031871
Insider Transaction Report
Form 4
SIECZKAREK MARK M
Director
Transactions
- Award
Warrant
2016-05-09+130,890→ 142,557 totalExercise: $1.91From: 2016-05-09Exp: 2020-05-05→ Common Stock (130,890 underlying)
Footnotes (1)
- [F1]Warrant acquisition pursuant to a securities purchase agreement, which is one of a series of securities purchase agreements that the company entered into for the sale of an aggregate of 2,039,530 warrants to 9 accredited investors. The company expects to sell another 1,047,121 warrants pursuant to those same agreements on July 31, 2016.
Documents
Issuer
NovaBay Pharmaceuticals, Inc.
CIK 0001389545
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001389545
Filing Metadata
- Form type
- 4
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 5:07 PM ET
- Size
- 5.1 KB